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Background: Dignity Therapy (DT), an intervention for people facing serious illness, focuses on dignity conservation
tasks such as settling relationships, sharing words of love, and preparing a legacy document for loved ones.
Research on DT began more than a decade ago and has been conducted in 7 countries, but a systematic review of
DT research has not been published.
Methods: Using a PubMed search with key terms of ‘dignity therapy’, ‘dignity psychotherapy’, ‘Chochinov’, and
‘dignity care’, we found 29 articles on DT and retained 25 after full-text review.
Results: Of these, 17 articles representing 12 quantitative studies establish that patients who receive DT report high
satisfaction and benefits for themselves and their families, including increased sense of meaning and purpose. The
effects of DT on physical or emotional symptoms, however, were inconsistent.
Conclusions: Conclusions point to three areas for future research on DT, to determine: (1) whether the DT
intervention exerts an impact at a spiritual level and/or as a life completion task; (2) how DT should be
implemented in real world settings; and (3) if DT has an effect on the illness experience within the context of not
only the patient, but also the family and community. Building on this body of DT research, investigators will need
to continue to be sensitive as they involve participants in DT studies and innovations to facilitate the generation
and delivery of legacy documents to participants near the end of life.
Keywords: Dignity therapy, Literature review, Spiritual care, End-of-Life careBackground
Care of the psychological and spiritual aspects of a per-
son during illness are recognized as essential compo-
nents of patient-centered care. That the achievement of
well-being in the face of incurable illness depends on
these aspects of a person’s experience is particularly well
acknowledged [1,2]. Research addressing social and psy-
chological needs during physical illness has become
more substantial in recent decades [1,3]. However, sys-
tematically developed, manualized, and well-studied
interventions for these dimensions lag behind those for
physical aspects of illness [4,5]. This paucity is even
more pronounced for spiritual care than it is in* Correspondence: l-emanuel@northwestern.edu
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unless otherwise stated.psychological and social care, despite growing evidence
for its importance [6-13].
Chochinov proposed Dignity Therapy (DT) as a psy-
chotherapeutic intervention for people facing serious
illness [14]. DT focuses on dignity conservation tasks
such as settling relationships, sharing words of love, and
preparing legacies of memory and shared values, all of
which take on a heightened importance at the end of
life. DT has some similarities with Butler’s Life Review
[15], which Butler understood as part of a life-cycle task
and developed as an antidote to depression in older
adults. Both DT and Life Review are conceptualized as
multi-dimensional psychosocial interventions for patient-
centered care [14,15]. Perceiving that dignity depends on
experiences of generativity and the pursuit of purpose and
meaning, Chochinov [16] identified aspects of dignity-
conserving care and proposed a model for its development,l. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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dignity for patients facing serious illness [16]. This model
includes spiritual as well as psychosocial and physical
elements.
Dr. Chochinov and his colleagues developed a manua-
lized guide for DT [17]. The intervention uses 10 core
questions that guide an interview, including “What are
your most important accomplishments, and what do you
feel most proud of? What are your hopes and dreams for
your loved ones? What have you learned about life that
you would want to pass along to others?” [17].
Responses are used to create a written legacy docu-
ment that the person shares with others important to
him or her. Dr. Chochinov and his team provide stan-
dardized training for DT on an annual basis. Pro-
fessionals from a range of disciplines deemed to have
suitable prior mental health-related training (e.g., psy-
chologists, social workers, chaplains, or physicians) from
locations across the globe attend this training. In their
manual, the steps of the DT intervention are described
in detail to allow intervention fidelity. During consent
and introduction to the DT process, the interventionist
describes DT as an opportunity to speak about issues
that he or she believes are most important and would
want preserved as part of a legacy-making exercise. The
DT session is audio-recorded, transcribed, edited, and
given back to the patient, who may give it to family
members or friends. The editing process gives the pa-
tient the freedom during the interview to share his or
her free-form thoughts, knowing that there will be a step
to reorganize and rework the transcript to produce a leg-
acy document that he or she feels is aesthetically plea-
sing, accurate in content, and not damaging to anyone.
The patient reviews the edited document and can then
give it to family and friends.
A number of studies of DT have been conducted over
the past decade. Multiple studies describe widespread
acceptability and high satisfaction among those who
experience DT. In contrast, rigorous evidence for any
beneficial effects of DT on important palliative care out-
comes has been limited. This contrast raised our cu-
riosity about how measured outcomes related to the
mechanism and timeline of DT’s impact; during this
inquiry, we noted that research on DT has not been sys-
tematically reviewed. The purpose of this article is to
provide a synthesis of findings from existing DT studies
regarding its feasibility, acceptability, and effects, and




We queried the PubMed database to obtain an initial list
of potential articles for review. As development of DTbegan in the 2000s, our searches included articles pub-
lished in that decade through July 2014. The initial
search terms were ‘dignity therapy’, ‘dignity psycho-
therapy’, ‘Chochinov’, and ‘dignity care’. As indicated in
Figure 1, following PRISMA guidelines for systematic re-
view [18] we identified and downloaded 57 references
into EndNote X4 (Thompson Reuters ISI ResearchSoft,
2014). We deleted duplicate articles and retained 28 arti-
cles. An additional in press study [19] that was known to
us (Linda Emanuel is a co-author) was added to the
references, for a total of 29 articles.
Selection criteria
The authors conducted a two-stage review, first of ab-
stracts and then of full text articles. All authors reviewed
both abstracts and articles from the review. We retained
only studies of DT as an intervention. The retained 25
articles included qualitative and quantitative studies of
the feasibility, acceptability, and effects of DT for pa-
tients (Figure 1). We excluded studies that focused on
the development of, or other application of, the dignity
therapy model (e.g., Hall et al. [20] Johnston et al. [21],
Li et al. [22]), studies of DT and the family (rather than
the patient), and other dignity or palliative care topics.
Results
Our search yielded 17 articles that represent 12 quantita-
tive studies of DT, which were led by principal investigators
who conducted the studies: during their research training
(3 studies); were experienced investigators (7 studies); or
were of unknown prior investigator experience (2 studies).
There were 8 uncontrolled feasibility studies and 4
randomized clinical trials (RCTs) for efficacy (Table 1)
[17,19,23-38]. There were also 5 qualitative studies of DT,
4 of which occurred in a sample already involved in one of
the quantitative studies (Table 2) [34,39-42]. Lastly, 3 case
reports of DT, including 2 in patients with mental illness
not at the end of life, and one in patients involved in
one of the quantitative studies, were found (Table 3)
[34,43,44]. In total, we reviewed 25 articles representing
15 separate studies.
Settings
The investigators of the quantitative studies recruited
samples from Canada, Australia, the United States, the
United Kingdom, Denmark, Portugal, and Japan. Their
sample sizes ranged from 8 to 441. Participants in these
studies were primarily people who were terminally ill or
had advanced cancer, and were receiving care either at
home, in a nursing home, or in the hospice or palliative
care units of a hospital. There were 2studies whose par-
ticipants were older adults living in long-term care
settings.
Records identified through 
database searching
(n = 57)
Additional records identified 
through other sources
(n =1 )





(n =  4)
Full-text articles assessed 
for eligibility
(n = 25)
Full-text articles excluded, 
with reasons
(n = 0)
Articles included in 
qualitative synthesis
(n =  25)
Representing 15 
independent studies
Figure 1 Flow diagram of systematic review process.
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The quantitative studies included 8 with a pre/posttest
single group design, 3 with a two-group RCT design,
and one with a three-group RCT design. Only one RCT
study [31] was adequately powered to test efficacy of the
DT intervention (Table 1). All but one study included a
baseline measurement before the DT intervention.
Studies included 1 or 2 measurements after the inter-
vention at intervals that varied substantially, from im-
mediately post-intervention (3 studies) to 2 months
post-intervention. These posttest measures typically
occurred within a week of the intervention (6 studies),
but also occurred 2 to 4 weeks after the intervention
(4 studies), and 2 months after the intervention (1 study).Intervention
Investigators used Chochinov’s DT protocol in all 12
quantitative studies. In one study, based on partici-
pant preference, the investigator expanded the legacy
document to include photographs, and delivered the
legacy book at a later time after the intervention than
the other studies [26]. Chochinov trained the DT
therapists for 8 studies. The type of training was not
specified for 3 studies [23,24,38], and in one study,
the investigator independently followed the published
literature on DT [26].Measures/approaches
In the quantitative studies, investigators used a variety
of measures to examine primary and secondary out-
comes. These included measures of: depression (9 stu-
dies), anxiety (6 studies), symptoms (4 studies), quality
of life (7 studies), hope (5 studies), spiritual well-being
(2 studies), dignity (7 studies), function (3 studies)
and other psychosocial or palliative care-related con-
cepts (5 studies). The tools for the designated primary
outcome in the efficacy studies were the Personal Dig-
nity Inventory (2 studies), Hospital Anxiety Depression
Scale (1 study), and other tools (1 study). The tools for
the secondary outcomes varied among the efficacy
studies as listed in Table 1. The DT Patient Feedback
Questionnaire was used in most of the quantitative
studies either as a measure of acceptability or as an
outcome measure. The investigators of the 5 qua-
litative studies used content analysis with coding con-
sensus as the main analytic technique. Additional
techniques included constant comparative analysis,
framework analysis, and co-occurrence analysis. The
case studies described novel cases of distressed
patients.
Based on the existing quantitative and qualitative
studies, we summarize key findings regarding the ac-
ceptability, feasibility, and effects of DT. Effects include
primary and secondary outcome findings.
Table 1 Dignity therapy studies




US sample; 8 pts with cancer
in hospice care
Single group pre-post trial of
DT via telemedicine
• ZSDS DT is feasible by
telemedicine/
videoconference.• PUBs













suffering (p = .023),
depressive symptoms
(p = .05).• Depression
100 terminally ill pts in




• Anxiety High proportions gave
positive evaluation for





• Desire for death
86% reported DT was helpful
or very helpful.• Suicide
• Sense of well-being 81% indicated DT had
already helped, or would
help, their family.QoL – 2 items
ESAS (revised) 76% indicated DT heightened
their sense of dignity.
Evaluation
DTPFQ 47% indicated DT increased
their will to live.
Akechi et al.,
2012 [24]
Japanese sample; Two trials of DT feasibility,
no control
Evaluation Major problems with
recruitment in Study 1 but
not Study 2. The authors raise
concern about acceptability
of DT in Japanese culture.
DTPFQ– 9 items
11 pts with advanced cancer
in hospice and hospital pall
care unit
Assessment: No schedule of
assessment reported
Overall positive evaluation of
DT: 67% indicated DT
heightened their sense of
dignity, 56% indicated DT
was beneficial, 78% indicated
DT had already helped, or
would help, their family.
Chochinov et al.,
2012 [25]
Canadian sample; Single group trial of DT Evaluation Cognitively intact: reports
helpful and satisfactory, but
no specification of benefits
around meaning, purpose,
dignity.
DTPFQ– 9 itemsAssessment: 2–3 days
post DT
12 cognitively intact and 11
cognitively impaired frail
elderly in long-term care
Cognitively impaired: proxy
participants (family members)
indicated DT is helpful to
them and their families.




Single group trial of DT • 7-item cancer distress
measure
4 completers (3 declined to
finish, 3 deaths); sample size
too small for statistical
analyses.• BDI
Assessment: Baseline & f/u 1
shortly post DT, f/u 2 within
1 month
• FACIT-PAL
Evaluation Feasibility and acceptability
reported from surviving
participants.DTPFQ
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Table 1 Dignity therapy studies (Continued)
Bentley et al.,
2014 [27,28]
Australian sample; Single group pre-post trial
of DT
• PDI Feasibility and acceptability
established.
• FACIT-SP High rating of satisfaction
(93%) and helpfulness (89%)
for DT.29 pts diagnosed with motor
neurone disease living in
community
Assessment: Evaluation
Baseline, f/u • DTPFQ
1 wk post DT • 3 additional single-item
measures of hopefulness &
family support.
No significant changes in
hope, spirituality or dignity.
Houmann et al.,
2014 [29,30]
Danish sample; 80 pts w
incurable ca from hospice
and hospital pall care unit
Single group pre-post trial
of DT
• SISC - 6 items No change on any measure
at f/u 1 or f/u 2 except QoL
decreased baseline to f/u 1.• PDI
• Quality of life: EORTC QLQ-
C15-
Assessment: At f/u 1 and f/u 2 positive
responses on DTPFQ.
Baseline, f/u 1 immediately
after receiving generativity
document (median 36 days
post DT), f/u 2 1 mo after DT
(median 60 days)
• PAL
• HADS Issues w recruitment (~50%)
• Palliative Issues w retention f/u 1 69%,
f/u 2 39%.
• Performance scale ver2
(PPSv2)
Evaluation Issues with floor effects
(30%-70% no sx on SISC/PDI).
DTPFQ– 9 items
Subgroup analysis for each
SISC/PDI item using those





US sample; Single group pre-post trial
of DT
• TIA DTPFQ indicates DT very
acceptable; increase in death
acceptance over time (11% at
baseline vs. 57% at f/u 2).






Baseline, f/u 1 • 2-item QOL








Canada, Australian, & US
sample
3 arm RCT: DT vs client-
centered care vs standard
care
Outcomes No significant differences on
any of the outcomes.
• Structured Interview for
Symptoms and Concerns
(SISC): 7 items
Pts in the DT group had
higher scores than the other
grps on 8 of 22 evaluation
items.
441 pts receiving palliative
care in hospital, hospice or
home
Assessment:
• Edmonton Sx – 8 items Issues with recruitment,
retention, floor effects.
• Quality of life: 2 items







DTPFQ– 22 itemsIntervention: psychiatrist,
psychologist, palliative care
nurses
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Table 1 Dignity therapy studies (Continued)
Hall et al.,
2011 [32,33,36]
UK sample Design RCT (Phase II trial for
acceptability, estimates of
effect sizes): Tx = DT plus
usual care; Control = usual
care
Primary: No differences on PDI.
• PDI No differences for any
secondary outcomes, except
higher hope in DT grp at f/u
1 (p = .02).
45 pts with advanced cancer Secondary:
• Hope
• HADS
• EQ-5D Patients in the DT group had
higher scores on DTPFQ,
some significant.Assessment: • palliative-related outcomes
(Hearn)
DTPFQBaseline, f/u 1 1 week post




UK sample Design RCT (Phase II trial for
potential effectiveness,
feasibility): Tx = DT plus usual
care; Control = usual care
Primary: No significant differences on
effectiveness measures at any
point; reduced dignity-related
distress as measured by
DTPFQ across both groups
(p = 0.026).





Acceptability: Patients in the DT group
significantly more likely to
feel DT had made life more
meaningful at f/u 1 (p = 0.04).
• DTPFQAssessment:
Baseline, f/u 1 7 days





Portuguese sample Design RCT: Tx = DT+ usual
care; Control = usual care
HADS DT associated with lower
depression at f/u 1 and 2
(p < 0.0001) and lower
anxiety at f/u 1, 2 and 3
(p < 0.0001).
60 terminally ill pts
Assessment:
Baseline, f/u 1 4 days
post-DT, f/u 2 15 days




BDI = Beck Depression Index; DTPFQ = DT Patient Feedback Questionnaire; EORTCQLQ-C15-PAL = European Organization for Research in Cancer Quality of Life
Questionnaire; EQ-5D = EuroQol; ESAS = Edmonton System Assessment Scale; FACIT-SP = Functional Assessment of Chronic Illness Therapy - Spiritual Well-Being;
FACIT-PAL = Functional Assessment of Chronic Illness Therapy – Palliative Care; GDS = Geriatric Depression Scale; HADS = Hospital Anxiety Depression Scale;
H-CAP-S = Hypothetical Advanced Care Planning Scenario; HHI = Herth Hope Index; NH = nursing home; PDI = Personal Dignity Inventory; PPSv2 = Palliative
Performance Scale; PUBs = Purposelessness, Understimulation and Boredom scale; QoL – 2 = Quality of Life; SISC = Structured Interview for Symptoms and
Concerns; TIA = Terminal Illness Acknowledgement; ZSDS = Zung Self-Rating Depression Scale.
Fitchett et al. BMC Palliative Care  (2015) 14:8 Page 6 of 12Acceptability
Evidence of DT’s acceptability is clear and consistent; pa-
tients who receive DT provide exceptionally high ratings
of satisfaction and benefits for themselves and their
families. For example, in a study of 100 terminally ill
patients in Canada and Australia who received DT,
Chochinov and colleagues reported that 91% reported
feeling satisfied or highly satisfied with DT, 76% indi-
cated that DT heightened their sense of dignity, and 47%
reported that DT increased their will to live [17]. Simi-
larly, among 29 Australian patients diagnosed with
motor neuron disease who received DT, 93% providedhigh ratings of satisfaction, and 89% reported high ra-
tings of helpfulness [28]. Among the participants in the
study by Chochinov and colleagues, 81% indicated that
DT had already helped, or would help, their family [17].
Feasibility
Recruitment and retention were issues for almost all of
the DT studies and a major problem for some. For
example, in a Danish study of patients with incurable
cancer, only 21% of potential participants were eligible,
it took two years to recruit a sample of 80 patients, and
only 31 patients (39%) completed the second follow-up
Table 2 Qualitative studies of dignity therapy
Study Sample Methods Main study finding
Hack et al., 2010 [39] 50 edited DT transcripts (17 Canadian
and 33 Australian) from patients with
terminal illness in inpatient palliative
care programs, sample from
Chochinov et al., 2005 [17]
Content analysis, constant comparative
analysis of completed DT legacy
document by three investigators
• Throughout DT interview patients
reflect on two to three personally
meaningful core values, such as
‘family’, ‘pleasure’, ‘caring’, and ‘sense
of accomplishment’.
• DT is used by patients to confirm
personal identity.
• Investigators suggest more
theoretical analysis of “meaning-
making” construct in end-of-life care
needed.
Tait et al., 2011 [40] 12 Canadian patients with terminal
illness in inpatient palliative care
Constant comparative analysis of DT
interviews
• Three main ‘types of interviews’
emerge: ‘Evaluation narratives’,
focusing on life prior to illness;
‘transition narratives’ , focusing on
change in health status and its
meaning; ‘legacy narratives’, focusing
on future without the patient.
• Investigators suggest narrative
themes share commonality with
medical interview and eulogy genres.
Montross et al., 2011 [41] 27 US community-based hospice
patients
Coding consensus, co-occurrence, and
comparison analysis of DT legacy
documents
• Similar findings to Hack et al., 2010
[39], core values consistently
expressed in transcripts.
• DT is feasible in a community-based
setting.
Hall et al., 2013 [34] 49 UK pts in older care homes, sample
from Hall et al., 2012 [35,36]
Framework analysis of qualitative
interviews conducted at T1 and T2;
interviews on resident views of DT
and/or being a study participant
(control group).
• Of 9 themes, 3 were unique to
intervention group: ‘views of legacy
document’; ‘generativity’; and
‘reminiscence’.
• DT not recommended by
investigators, in current form, with
participants with cognitive
impairment: findings suggest DT
document may reflect ‘distorted
sense of self’ and prompt distress.
Hall et al., 2013 [42] 29 UK pts with advanced cancer,
sample from Hall et al., 2011 [32,33]
Framework analysis of qualitative
interviews conducted at T1 and T2;
interviews on pt views of DT and/or
being a study participant (control
group).
• 5 of 7 themes in Dignity Model
theory present in both interviews
groups; ‘generativity’ found only in
intervention group.
• No evidence of ‘role preservation’ as
described in Dignity Model in this
sample.
• Qualitative interview reporting of
higher levels of hopefulness in both
groups from participating in study,
despite no change in quantitative
component of study.
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the UK with advanced cancer, the recruitment rate was
24%, 60% of the participants completed the 1-week
follow-up assessment, and only 44% completed the
1-month follow-up [33]. In an RCT of DT among 60 ter-
minally ill Portuguese patients, only 30 (50%) were avail-
able for the 30-day follow-up assessment [37]. Problems
with recruitment and retention are not unexpected inresearch with persons with advanced illness receiving
palliative care [45] and they clearly affected these studies
of DT.
Effectiveness
In single group studies, DT often showed significant
changes in study outcomes. When compared to usual
care control groups, however, DT effects were often not
Table 3 Case reports of dignity therapy use
Study Sample Implementation Discussion
Avery & Savitz, 2011 [44] US patient with schizoaffective
disorder in inpatient psychiatric unit
DT protocol questions used by patient
to write life story, prompted by worries
of not spending time with family
because of illness. Investigator typed
and edited narrative and discussed
with patient.
• Patient reported that narrative had
‘restored hope’ to him. Patient shared
copies of document with loved ones.
• Investigators note DT could be
beneficial for pts with chronic mental
illness, “improving patient narratives”.
Avery & Baez, 2012 [43] US patient with major depressive
disorder in inpatient setting
DT protocol used by investigator to
aid patient in ‘gaining fresh
perspective’ after severe depression
following loss of job.
• Patient reported DT aided her in
‘finding hope’, and improved her
mood.
• Investigator notes use of DT to make
sense of major life event and loss.
• Investigator posits DT legacy
document may be supportive to
family members of patients with
chronic mental illness.
Hall et al., 2013 [34] 3 UK patients with advanced cancer in
high distress, sample from Hall et al.,
2011 [32,33]
Focus on ‘dignity-related problems’
expressed by patients, qualitative
review of DT legacy documents.
• Investigators note DT administered in
a context of complex and quickly
changing circumstances.
• Distressed patients may find focus on
‘overarching truths, feelings and
insights’ as indicated in DT protocol
very difficult.
• DT therapeutic relationship is
challenging with patients who are
distressed given short time-frame of
interaction.
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to detect small or moderate effects in study outcomes
(sample size = 441, divided into 3 groups). In that study,
compared to participants in the other study arms, there
were no significant differences for any primary outcomes
for participants who received DT. The other 3 RCTs
were much smaller (n = 45, 60, or 64) and may have
been underpowered [33,36,37]. However, in one of those
studies, compared to usual care controls, participants
who received DT had significantly lower levels of anxiety
and depression at follow-up [37]. In the 3 RCTs that ex-
amined satisfaction with DT, compared to those who did
not received DT, participants who received DT reported
higher levels of meaning in life, quality of life, and spiri-
tual well-being post-intervention [31,33,36].
Discussion
In contrast to the strong evidence of the acceptability of
DT, the existing studies raise several questions about
DT’s feasibility and efficacy. We take up these questions
below.
The nature of DT and how to measure what it does
In the largest, most definitive study of DT to date, the
absence of effects on many outcomes immediately after
DT is striking, especially in view of how positively par-
ticipants report their response to DT. This conclusion iscritical. From the scientific evidence, we cannot yet say
if DT is efficacious, what it is efficacious for in the short
term, or why reported effects emerge later in a single
group study. This may be an issue of what is being
measured. One possible explanation, noted by Hall and
colleagues [33], is that DT does not directly address
physical symptoms or functions, and thus it is a mistake
to use as primary outcomes measures that include them,
such as those in the Personal Dignity Inventory.
The possible need to use delayed measurement is
raised by Vergo and colleagues’ small (n = 15; 88% par-
ticipation) feasibility study of DT among outpatients
with stage IV colorectal cancer actively receiving second
line chemotherapy [19]. Because the investigators were
interested to know if DT improves a person’s existential
maturity (comfort with their mortality) [46], outcomes
included death acceptance (peaceful awareness and
treatment preferences). Although the study was small,
its findings suggest DT may contribute to increased un-
derstanding of the terminal nature of their disease, and
less aggressive end-of-life goals of care. Specifically,
there appeared to be an increase in death acceptance
over time (11% at baseline and 57% at 1 month post-
DT), raising the possibility of a delayed effect, which is
consistent with findings from other studies of group dif-
ferences in effects that occurred a week or more after
DT [31,37].
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multiple dimensions, we are particularly interested in its
action in the spiritual dimension of peoples’ lives. DT’s
conceptual framework includes a spiritual component,
and recent work indicates a taxonomy of chaplaincy ac-
tivities reasonably aligned with most DT components
[47-49]. As people age, many become more spiritually
inclined as a life-cycle phenomenon [50,51]. A substan-
tial body of evidence describes the relationship between
religious involvement and beliefs and preferences for
end-of-life care, as well as the care actually received;
generally, higher levels of religious involvement are asso-
ciated with preferences for and receipt of life-prolonging
treatment [52-55]. While this association has been ob-
served in multiple studies, the reasons for it are less
well-understood. One possibility is that unfinished spi-
ritual or religious tasks led to preferences for life-
prolonging care at the end-of-life [56]. We propose that
DT should be studied as a spiritual as well as a psycho-
social intervention that assists with the existential tasks
faced by the majority of elderly patients, especially as
they encounter a life threatening illness like cancer. Our
conceptualization of DT as an intervention with a strong
spiritual element leads us to note that, while they have
not been used in prior studies, measures of the exis-
tential tasks associated with the end of life, as well as
dignity impact, are appropriate outcome measures for
studies of DT. For instance, studies to further investigate
the preliminary findings by Vergo and colleagues on
DT’s impact on illness acceptance and care goals will be
important.
We also note that, as described in the model for un-
derstanding care of the human spirit (in this issue), the
mechanism of action of a spiritual intervention might
have unique features, such as its timing and interactions
with the other main spheres of human experience.
Therefore, careful thought about what might mediate
DT outcomes is warranted. For instance, pain, depres-
sion, or role incompletion might mediate outcomes, per-
haps limiting desired and amplifying undesired states.
Or if, as the model hypothesizes, there is a reciprocal
interaction between spheres, this might explain the im-
pact of DT, which might act through multiple spheres to
have a primary spiritual impact. Further understanding
will require creative approaches, perhaps even involving
bundled interventions, and a reconsideration of outcome
measures.
Some of these issues will be challenging to resolve be-
cause of the feasibility of conducting studies of DT.
As has been noted [45], recruitment and retention is
challenging in seriously ill populations. If, in determining
the ideal interval between the completion of DT and
follow-up assessment of outcomes, it appears that more
time is needed – either to allow for changes that mayemerge over time as the participant reflects on the DT
experience, or as changes occur that may result from the
participant sharing his or her legacy document with sig-
nificant others – the retention issue may be exacerbated.
That is, both of these potential reasons suggest a longer
interval is needed before follow-up assessment, at least
one week, and perhaps longer. However, the tradeoff is
that longer intervals are associated with serious attrition
due to deteriorating health or death.
Related to issues of recruitment and retention is the
fact that patients who are experiencing higher levels of
distress may be less likely to volunteer to participate in
DT studies, or to complete them. This appears to have
been the case in some studies of DT where the investiga-
tors noted the low levels of distress in the samples they
recruited [31,33,36]. This results in ceiling and floor ef-
fects in the measures of pre-intervention distress that
preclude an intervention such as DT from having any
measurable effect on those outcomes [57,58]. One so-
lution is to screen and select study participants for
elevated pre-intervention distress, a choice that would
likely exacerbate issues with recruitment.
Aside from issues of feasibility of DT research, there is
emerging evidence about the feasibility of DT in rou-
tine clinical practice. In their study of DT with 27 pa-
tients in a community-based hospice, Montross and
colleagues [41] reported that the mean number of ses-
sions for completion of DT was 4, with an average of
6.3 hours devoted to DT per patient. This estimate did
not include the time required for editing the DT legacy
documents (see Hall et al.’s report [36] of personal com-
munication with Montross). In the Montross et al. study,
the average length of the legacy documents was 8 single-
space pages, which, at a transcription cost of 13 cents
per line of text, yielded an average transcription cost of
$56 (range $27 to $144) per document. This team con-
cluded these costs were “reasonable and at a level that is
readily sustainable for the organization” (p. 733 [41]). In
contrast, in their study of DT with older adults living in
care homes, Hall and colleagues [36] reported an average
of 4 hours for transcription of the legacy documents and
a total time for DT of 15.04 hours (SD = 7.13), which in-
cluded time for the DT interview, transcription, and
returning and revising the legacy document. In this
study, for 30% of the participants, 4–6 visits were re-
quired to review and revise the legacy document, in part
because in subsequent visits participants recalled add-
itional information they felt should be included.
A remaining clinical feasibility question relates to who
should administer DT in a real-life care setting. A
reasonable approach to this question would be to con-
ceptualize the dignity therapist either as a generalist
(physicians, nurses) or a specialist (psychologists, chap-
lains). Within palliative care teams, it is most likely that
Fitchett et al. BMC Palliative Care  (2015) 14:8 Page 10 of 12nurses or chaplains could absorb DT as part of their rou-
tine work. In a prior RCT [31], a research nurse admin-
istered the DT, with significant efficacy findings. Further,
the nursing discipline’s focus on holistic care, inclusive
of spirituality, makes this discipline a strong candidate
[21]. Johnston et al. [21], recommended a nursing inter-
vention derived from the Chochinov dignity model – the
dignity care pathway – to assist nurses in conserving
patient dignity at the end of life. However, although the
ratio of nurses to patients is suitable, nurses already have
a heavy workflow that may be sidetracked by DT unless
carefully scheduled.
Recent findings [56] also indicate that clinicians from
nursing and medicine look to board certified chaplains
as the health care professionals with the expertise to
provide spiritual care [9]. Chaplain-to-patient ratios and
chaplain assignments are not currently suitable for the
routine offering of DT, but chaplains might be more
interested in DT than nurses due to significant and
growing demand for evidence-informed interventions
for chaplains. Studies are needed to evaluate DT efficacy
by different health care professionals and in diverse set-
tings. For instance, where the therapy should be done,
and when in the sequence of the patient’s clinical en-
counters, who should transcribe the interview, how to
return the legacy document, and how long an interval
between transcription and delivery is suitable, etc. are
not established for clinical practice. The impact on the
flow of the team’s work, and the chaplain or nurse in
particular, is not known.
Who should receive DT?
Although our review focused solely on uses of DT as an
intervention for patients, a small body of literature is de-
veloping in which investigators are studying the effects
of DT on family members of patients who have par-
ticipated in DT. As noted in Table 1, Chochinov et al.
[25] present a novel use of DT by proxy family members
of patients with cognitive impairment. The majority of
family members involved indicated they would recom-
mend it to other long-term care residents and their fam-
ilies. Goddard et al. [59] report similar findings of family
member recommendations for DT in a long-term care
setting. In a study for family caregivers of those with
motor neuron disease [60], the investigators report that
family caregivers identified benefits to the patient par-
ticipating in DT, and to themselves during bereavement,
but they present mixed findings about the acceptability
of the intervention to family members at the time of the
intervention. The investigators recommend that dignity
therapists be sensitive to acceptability issues and the
quality of patient and family caregiver relationships.
Other preliminary investigations into the receptivity and
acceptance of DT by family members [61], [26] andhospice staff [62] are reported in the literature. Together,
these studies present rich but preliminary evidence that
DT has positive effects not only on the patients who re-
ceive it, but on their families and caregivers. In addition
to mechanism and efficacy studies of DT, more research
is needed to enhance understanding of the best practices
in implementing DT in consideration of family members
and others involved in patient care.Conclusion
Our literature review finds robust evidence for DT’s
overwhelming acceptability, rare for any medical inter-
vention, especially in psycho-social-spiritual care. This
evidence exists despite challenges to the feasibility of DT
because of recruitment and retention difficulties among
very ill populations. Potentially exacerbating this chal-
lenge for future studies, it remains possible that mea-
sures for DT should occur a week or more after the
intervention to capture its impact. The evidence for
DT’s immediate efficacy is lacking in the only fully pow-
ered RCT so far available, in which significant impact
was limited to secondary outcomes only measured post-
intervention. However, smaller studies did find effects
for increased hopefulness [32,33,36] and lower depres-
sion and anxiety [37,38]. DT was designed based on an
empirically derived model and includes elements from
several domains of the human experience; its measures
have reflected this. Nonetheless, available evidence sug-
gests that the mechanism of DT action may not be re-
lated in a straightforward way to its underlying model.
In particular, we perceive that its mechanisms may be
related to role completion and spiritual aspects of a per-
son’s life. In addition, and relatedly, we note that clinical
feasibility studies are needed for DT. It is important to
establish how best to implement such a well-received
intervention into clinical practice. We suggest that fu-
ture research on DT should focus on three main areas.
The first pertains to the nature of the intervention, espe-
cially the possibility that its main impact is in a spiritual
dimension. The second relates to how DT should be im-
plemented in real world settings. The third relates to the
reality that illness is experienced not only by the patient
but by the family and community.Competing interests
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